Ketosis and ketoacidosis in hospitalized patients receiving <scp>SGLT2</scp> inhibitor therapy
Ketosis following inpatient SGLT2i administration was infrequent and generally occurred in the setting of known precipitants. These results suggest that, in hospitalized patients selected by clinicians to receive SGLT2i, clinically significant ketone accumulation is low in prevalence.
Authors
- Elif Ilhan Ekinci (ORCID: https://orcid.org/0000-0003-2372-395X)
- Rinaldo Bellomo (ORCID: https://orcid.org/0000-0002-1650-8939)
- Meg Stevens (ORCID: https://orcid.org/0000-0003-0553-7686)
- Leonid P. Churilov (ORCID: https://orcid.org/0000-0002-9807-6606)
- Dinesh Pandey (ORCID: https://orcid.org/0000-0003-2128-5570)
- Hossein Jahanabadi (ORCID: https://orcid.org/0000-0002-8431-6779)
- Ashani Lecamwasam (ORCID: https://orcid.org/0000-0002-1960-2242)
- Kartik Kishore (ORCID: https://orcid.org/0000-0002-6254-6063)
- Frank M. Gao (ORCID: https://orcid.org/0009-0005-0789-307X)
Institutions
- The Royal Melbourne Hospital (AU)
- The University of Melbourne (AU)
- Northern Health (AU)
- Austin Hospital (AU)
- Australian and New Zealand Intensive Care Society (AU)
- Melbourne Health (AU)
- Austin Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1111/dom.70029
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Australian Government
- University of Melbourne